Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;27(5):2844-2856.
doi: 10.1111/dom.16294. Epub 2025 Feb 25.

Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male mice

Ailin Zhang  1 , Qinhui Liu  2 , Yimin Xiong  2 , Jiahui Li  2 , Ying Xu  2 , Haiying Song  2 , Xiandan Jing  2 , Haixia Xu  2 , Na Yang  2 , Yanping Li  2 , Li Mo  3 , Qin Tang  2 , Jinhan He  1   2
Affiliations

Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male mice

Ailin Zhang et al. Diabetes Obes Metab. 2025 May.

Abstract

Aims: Tirzepatide, a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, demonstrates promise as a potent medication for obesity. However, the extent to which its weight-reducing effects go beyond suppressing appetite remains unclear. This study aimed to elucidate this by establishing a pair-fed control group, effectively eliminating the influence of reduced caloric intake.

Materials and methods: Mice fed on a chow diet or a high-fat diet received single or long-term intracerebroventricular (i.c.v.) injections of tirzepatide or vehicle. The vehicle-treated mice were pair-fed to the tirzepatide-treated group to avoid the impact induced by different caloric intakes. Body weight and food intake were monitored daily. Respiratory exchange ratio (RER) was determined in metabolic cages. Fat utilization was calculated based on RER. Parameters of lipid metabolism were evaluated.

Results: Mice receiving i.c.v. administration of tirzepatide exhibited significant reductions in body weight and fat content compared with pair-fed controls. These effects were mediated by increased lipolytic capacity in white adipose tissue and enhanced thermogenesis in brown and beige adipose tissues, leading to decreased RER and increased lipid utilization. Mechanistic investigations revealed that these effects were primarily mediated by sympathetic nervous system innervation of adipose tissues. This innervation, in turn, might be associated with the neuronal activity changes in the dorsomedial hypothalamus and the nucleus of the solitary tract within the hindbrain.

Conclusions: These findings establish a critical role for tirzepatide in shifting the substrate preference to fat utilization through the central nervous system-adipose tissue axis, promoting weight loss independent of food intake.

Keywords: GIP; GLP‐1 analogue; animal pharmacology; antiobesity drug.

PubMed Disclaimer

References

REFERENCES

    1. Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477‐1500. doi:10.1161/CIRCRESAHA.120.316101
    1. Bessesen DH, Van Gaal LF. Progress and challenges in anti‐obesity pharmacotherapy. Lancet Diabetes Endocrinol. 2018;6(3):237‐248. doi:10.1016/S2213‐8587(17)30236‐X
    1. Bhaskaran K, dos‐Santos‐Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause‐specific mortality: a population‐based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944‐953. doi:10.1016/S2213‐8587(18)30288‐2
    1. Hill JO, Wyatt HR, Peters JC. Energy balance and obesity. Circulation. 2012;126(1):126‐132. doi:10.1161/CIRCULATIONAHA.111.087213
    1. Myers MG, Affinati AH, Richardson N, Schwartz MW. Central nervous system regulation of organismal energy and glucose homeostasis. Nat Metab. 2021;3(6):737‐750. https://www.nature.com/articles/s42255-021-00408-5